Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation

Publication Date: July 31, 2022
Last Updated: August 23, 2023

Prevention of Hyperbilirubinemia

If the maternal antibody screen is positive or unknown because the mother did not have prenatal antibody screening, the infant should have a direct antiglobulin test (DAT) and the infant’s blood type should be determined as soon as possible using either cord or peripheral blood. (B, R)
1986747

Assessment and Monitoring for Hyperbilirubinemia

Use TSB as the definitive test to guide phototherapy and escalation-of-care decisions, including exchange transfusion. (X, R)
1986747

Overview

Title

Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation

Authoring Organization

American Academy of Pediatrics